New Nordic Healthbrands (NNH.ST) Stock Analysis & AI Equity Report
New Nordic Healthbrands (NNH.ST) overview
New Nordic Healthbrands (NNH.ST) stock analysis and AI equity research. For the latest completed financial year, 2025, New Nordic Healthbrands reported revenue of SEK 576m and operating profit of SEK 15.1m; the year-end share price was 23.20 SEK and market capitalisation was SEK 144m. New Nordic Healthbrands is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get New Nordic Healthbrands's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2026-07-27. Data will be refreshed during report generation.
About New Nordic Healthbrands
New Nordic Healthbrands develops and markets dietary supplements, natural medicines and cosmetic products aimed at specific health and beauty needs. Its brands are sold in pharmacies, health stores, beauty shops and travel retail across multiple countries, supported by local sales and marketing units in key markets. The company is headquartered in Malmö, Sweden.
Generate the New Nordic Healthbrands report
New Nordic Healthbrands is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for New Nordic Healthbrands and represent the latest completed financial year (2025). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.